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ABSTRACT 
Aim: Osseointegration of titanium implants is predictable, but can be improved via 
surface functionalization.  
Materials and Methods: 120 implants were installed in parietal bone of 12 domestic 
pigs and left to heal for 1 or 3 months. Five groups were defined according surface 
treatments: immersion in water (H2O), 10% polyphosphoric acid (PPA10), 1% 
phosphorylated pullulan (PPL1), 10% phosphorylated pullulan (PPL10), or 10% 
phosphorylated pullulan + 1 µg BMP-2 (PPL10 BMP). As primary outcome, implant 
osseointegration was evaluated by quantitative histology, namely peri-implant bone formation 
(B/T in %) and bone-to-implant contact (BIC in %) for each healing period. The Wilcoxon 
signed-rank test and Mann Whitney U-test with α=0.05 were performed.  
Results: PPL10 and PPA10 groups showed significantly higher B/T and BIC results 
than the control (H2O) group at 1-month (p<0.05). No significant difference was found 
between PPL1 and H2O or between PPL10 BMP and H2O, irrespective of healing time (1 or 
3 months) or investigated parameter (B/T and BIC; p>0.05). After 3 months, no experimental 
group showed a significant difference compared to the control group (H2O) for both 
investigated parameters (B/T and BIC; p>0.05).  
Conclusion: Functionalizing titanium implants with inorganic or organic phosphate-
containing polymers at 10 wt% concentration may stimulate peri-implant bone formation and 
implant osseointegration at early healing times. 
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CLINICAL RELEVANCE 
Scientific rationale for the study: To investigate the influence of different implant surface 
treatments on the efficiency of bone regeneration in a simulated clinical situation.  
Principal findings: Both PPA10 and PPL10 seem to induce faster peri-implant 
osseointegration and bone regeneration. Use of PPL as a carrier for BMP-2 was not efficient 
on stimulating peri implant bone formation. 
Clinical implications: PPA10 and PPL10 may promote more favorable conditions for early 
implant loading, particularly in unfavorable clinical situations. 
 
ACKNOWLEDGEMENTS 
This study was funded by the KU L uven Research Fund, grant number OT06/55. 
 
INTRODUCTION 
Aiming the enhancing of the osseointegration, implant surface modifications were 
developed over the years (Steigenga et al. 2003, Wennerberg & Albrektsson 2010). Different 
implant surface treatments have been investigated (Taxt-Lamolle et al. 2010, Wennerberg & 
Albrektsson 2010).
 
Bioactive functionalization of the titanium surface by chemical 
modifications is some of these (Liu et al. 2007, Choi et al. 2012, Jimbo et al. 2012). 
Especially when the protocol of rehabilitation is anticipated, a fast and effective 
osseointegration is necessary. Whenever the loading of the implant is required at early stages 
of peri-implant bone healing, a faster tissue regeneration is desirable to assure a more 
predictable clinical outcome. This becomes particularly important in less favorable bone 
conditions which are usually related to systemic disorders or implantation-site defects. By 
improving the peri-implant tissue regeneration, some common clinical problems could be 
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avoided. Unfortunately, this remains a challenge for clinicians and researchers (Esposito et al. 
2013). 
The functionalization of implants with fluoride has been studied and is commonly used 
in clinical practices (Steigenga et al. 2003, Mertens & Steveling 2011, Choi et al. 2012). 
Despite showing a positive effect on the osteoconductivity of titanium, functionalization with 
calcium phosphate has been only experimentally investigated (Paital & Dahotre 2009), due 
the presence of some inconveniences, as non-uniformity in crystallinity and morphology, low 
mechanical properties and poor adherence to the substrate (Paital & Dahotre 2009), limiting 
its clinical application. Recently, a simple and cost-effective treatment has been suggested for 
the surface functionalization of titanium implants by coating them with an inorganic 
phosphate polymer, namely polyphosphoric acid (PPA). This treatment seems to provide 
promising results on bone-like cell attachment, proliferation and differentiation (Maekawa et 
al. 2007) and on the promotion of direct bone bonding to titanium (Maekawa et al. 2009).  
It is well-known that phosphates are present in human osteoblasts, indicating a possible 
correlation between bone cell differentiation and phosphate groups (Leyhausen et al. 1998). It 
has been demonstrated that polyphosphates induce maturation and calcification of bone-
related cells (Kawazoe et al. 2004, Gopalakrishnanchettiyar et al. 2009). In in vitro 
conditions, the surface phosphorylation of biomaterials has been considered as a potential 
technique to impart biomimetic nucleation and mineralization of calcium phosphate on 
biocompatible surfaces (Anselme et al. 2000, Sailaja et al. 2009) thus providing preferential 
binding sites for bone cells. 
Besides inorganic phosphate polymers, the use of an organic biopolymer, pullulan, has 
been successfully applied in bone tissue engineering (Cheng et al. 2007, Kato et al. 2007, 
Fujioka-Kobayashi et al. 2012). Pullulan is an exocellular homopolysaccharide produced by 
the fungus Aureobasidium pullulans (Prajapati et al. 2013) and it has been studied as food 
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additives to environmental remediation agents (Cheng et al. 2011). The use of pullulan in 
biomaterial research is justified by its proven biocompatibility, drug delivery properties 
(Morimoto et al. 2005, Kato et al. 2007, Prajapati et al. 2013), cell stimulation (Thébaud et al. 
2007) and unique linkage pattern, including adhesive ability and the capacity to form thin and 
transparent biodegradable films (Prajapati et al. 2013). Moreover, another important 
advantage of pullulan over polyphosphoric acid is its ability to effectively act as a carrier to 
growth factors for bone tissue engeneering (Fujioka-Kobayashi et al. 2012). 
Pullulan presents hydroxyl groups which can easily be substituted by grafting different 
chemical groups (Prajapati et al. 2013). In that respect, Cardoso et al. (2014) have described a 
method for phosphorylation of pullulan (PPL) and showed osteogenic-promoting results by 
treating titanium surfaces with a solution of 10 wt% phosphorylated pullulan. However, 
macro-design of dental implants, insertion torque, achievement of implant stability and the 
presence of trabecular bone structure - important clinical aspects - were not taken into 
account, thereby urging the need for a follow-up study in a larger animal model in which most 
clinically relevant aspects could be taken into account. For this purpose, implantation of 
functionalized threaded implants in the bone of swine has been employed taken into account 
the similarities with human beings in terms of bone anatomy and metabolism (Pearce et al. 
2007). Subsequently, well-stablished histomorphometrical analyses can be carried out based 
on quantitative observations, namely bone density and bone-to-implant contact, both equally 
important aspects for the stabilization of implants under functional loading (Lutz et al. 2008, 
Cardoso et al. 2014). 
Considering the functionalization of implants with phosphate-based polymers as an 
alternative approach to foster bone healing processes (Cardoso et al. 2014) and the potential 
of pullulan to serve as a carrier to growth factors for bone engineering (Fujioka-Kobayashi et 
al. 2012), this study aimed to evaluate the influence of PPA and PPL on peri-implant bone 
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regeneration, the latest being produced at different concentrations and once adsorbed with a 
specific osteoinductive protein, namely bone morphogenetic protein 2 (BMP2). It has been 
hypothesized that the functionalization of the implant surface with phosphate-based polymers 
could accelerate and improve bone regeneration and that this improvement could be 
maintained over time. 
 
MATERIALS AND METHODS 
Animal model 
This study was approved by the Ethical Committee for Laboratory Animal Research of 
the Catholic University Leuven (P141-2009). Animals were handled according to the 
Directive for the Protection of Vertebrate Animals used for Experimental and other Scientific 
Purposes (86/609/EEC) and the Royal Belgian animal welfare regulations and guidelines. 12 
six-month old female domestic pigs (Sus scrofa domestica, Collaert, Hoegaarden, Belgium) 
were employed. Under circadian day and night rhythm, they were housed on straw at 
favorable conditions of temperature and humidity. Food (standardized pig mast fodder, 
Garant Tiernahrung GmbH, Pöchlarn, Austria) and water were supplied ad libitum. Their 
weigh ranged from 103 to 124 kg at the moment of the surgical procedure. All animals were 
observed throughout the study by a veterinarian and a veterinary technician to assure 
appropriate health conditions. The study has been carried out from February/2010 to 
February/2011. The animal experiment (period between the surgical intervention of the first 
animal and sacrifice of the last animal) occurred between early June and early August/2010. 
During this period, all efforts were considered to minimize suffering and no pathologic signs 
or symptoms were observed. This manuscript followed the ARRIVE guidelines for reporting 
animal research (Kilkenny et al. 2010). 
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Sample size was estimated according to previous literature and experience. International 
standards stablish that at least 2 animals should be used for each treatment at each healing 
time when implantation of biomaterials in bone of pigs is considered (Pearce et al. 2007). 
Previous research using the same methodology and implantation site (Lutz et al. 2008) 
showed that the use of 4 animals were sufficient to assure statistical significance. To 
compensate possible drop-outs, while minimizing the number of animals, the sample size in 
the present study was estimated to be n = 6, i.e. 12 animals in total. This number has been 
confirmed to be sufficient to assure statistical significance in our previous research in which 
the same methodology was employed (Cardoso et al. 2017). 
 
Implants 
Sixty custom-made titanium implants were machined to present 2 threaded parts, each 3 
mm in length and with an outer diameter of 1.8 mm, separated by a non-threaded groove of 1 
mm in length and a diameter of 1.1 mm (Fig. 1A and 1B). The threaded part was designed to 
be in contact with the host bone (immediate bone-to-implant contact) while the grooved part 
was designed to be kept away from the walls of the surgical site (no immediate bone-to-
implant contact), thus defining two regions of interest to be separately evaluated: groove (G) 
and thread (T). After machining, all implants were cleaned with acetone in an ultrasonic bath, 
washed with distilled water for three times and acid-etched in a solution containing 4 vol% 
hydrofluoric acid (HF 40%; Riedelde Haen, Heverlee, Belgium) and 20 vol% nitric acid 
(HNO3 65%; ChemLab, Zedelgem, Belgium) at room temperature for 60 s. Implants were 
then washed three times in distilled water and taken for standard autoclave sterilization in 
individual titanium containers. 
Implants were then divided into 5 groups defined by 5 different surface treatments, 
namely immersion in distilled water (H2O, control group), 10% polyphosphoric acid 
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(PPA10), 1% phosphorylated pullulan (PPL1), 10% phosphorylated pullulan (PPL10), or 10% 
phosphorylated pullulan + 1 µg BMP-2 (PPL10 BMP). In the control group, implants were 
simply stored in distilled water for 24 h at 37
o
C. Treatment of the implants with PPA10 was 
done by immersion in 10 wt% PPA solution for 24 h at 37°C. This solution was obtained by 
dissolving 10 g of 100% PPA (Merck Schuchardt, Hohenbrunn, Germany) in 100 ml of 
distilled water. For all groups treated with PPL (PPL1, PPL10 and PPL10 BMP), 
phosphorylated pullulan solutions were obtained by dissolving PPL powder in sterilized 
distilled water in concentrations of 1 wt% or 10 wt%. In order to increase the reactivity of the 
polymer, PPL solutions had their pH assessed and lowered to pH 5 by gradual addition of 
hydrochloric acid 0.1M until the specified pH was reached. They were then filtered using a 
GD/X polyethersulfone 0.2 µm filter (Whatman, Maidstone, UK). After treatment with 
PPA10, PPL1 or PPL10, samples were washed in demineralized water and air dried for 20 
min at room temperature. In the group PPL10 BMP, samples were initially treated with 10 
wt% PPL solution as described above. Subsequently, 10 µL of a 10% BMP2 solution was 
applied on each implant surface for the adsorption of 1 µg of the mentioned protein. This 
solution was obtained by re-constituting 10 µg of BMP-2 (RD Systems, Minneapolis, MN, 
USA) in 100 µL of phosphate-buffered saline (PBS) according to manufacturer’s instructions. 
To maintain the bioactivity of the protein, the adsorption of 10% BMP2-PBS solution onto 
the PPL-treated surfaces was carried out shortly before the surgery. Care was taken to avoid 
contamination of the protein and to keep the environmental temperature constant to avoid 
protein denaturation. The synthesis of PPL was processed as previously described in detail by 
Cardoso et al. (2014). All treatment steps were performed under sterile conditions. 
Four additional titanium plates were prepared and treated with H2O, PPA10, PPL1 or 
PPL10 as described above. These samples were used for spectrophotometric analysis of the 
colorimetric reaction of the phosphate-molybdenum compound (Han et al. 2016) in order to 
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evaluate the amount of phosphate-containing polymer on the treated titanium surfaces. For 
molybdenum blue measurement, the specimen were immersed in 20 ml of 1 wt% sulfuric acid 
solution for 30 minutes at 70
o
C. The solution in which each specimen was immersed was 
corrected for molybdenum blue measurement. The phosphoester compound in the sample 
solution was decomposed with potassium persulfate in autoclave. Concentration of resulted 
phosphate ions in the supernatant liquids were then measured via molybdenum blue reaction. 
For the molybdenum blue reaction, 0.6 g of ammonium molybdate tetrahydrate and 0.024 g of 
potassium antimony tartrate hydrate were dissolved in 30 mL deionized water. To produce the 
color reagent solution, 10 mL of 7.4 M concentrated sulfuric acid, 10 mL of 0.44 M 
ammonium sulfamate, and 10 mL of 0.4 M L-ascorbic acid were added. Subsequently, 1 mL 
of the color reagent solution was added to 6 mL of the sample solution. The absorbance of the 
molybdenum blue was recorded using a spectrophotometer (U-1900, Hitachi High-
Technologies Corporation, Tokyo, Japan) over time or read at 883 nm after 30min. For each 
sample, duplicate measurements were performed. 
 
Surgical protocol 
The animals were pre-anesthetized with 1 mL of butyrophenone i.m. (Stresnils
®
, 
Ausrichter, Annandale, Australia) and anesthetized by intravenous injection of a premixed 
combination of tiletamine and zolazepam (Zoletil 100
®
, Virbac, Barneveld, the Netherlands), 
added at 1/6 dilution to Xylazine (Vexylans, CEVA, Brussels, Belgium), and injected at 1 
mL/10 kg. The anesthesia was maintained by isoflurane at 1.5% concentration (IsoFlos, 
Abott, Quebec, Canada).  After applying local anesthetic subcutaneously at the surgical site 
(Lignospan, Septodont, Cedex, France), a sagittal incision was made and the soft tissues and 
periosteum were mobilized. Five implantation sites were drilled in a transversal sequence in 
the parietal bones 0.6 mm far from the coronal suture (Fig. 1C and 1D). Two of these sites 
Page 9 of 48
Journal of Clinical Periodontology - PROOF
Journal of Clinical Periodontology - PROOF
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
 
were drilled on the right parietal bone while the other three on the left parietal bone, always 
keeping a distance of 12 mm between adjacent drilling sites. The drilling sequence (speed of 
1500 rpm with water cooling) was: (1) guide drill (round bur); (2) twist drill (diameter of 1.2 
mm); (3) twist drill (diameter of 1.5 mm) and (4) twist drill (diameter of 1.7 mm). This 
resulted in a difference of 0.1 mm between the diameter of the final drill and the implant. Five 
implants, one of each of the five groups described above, were installed. Sites of implantation 
were randomly allocated to experimental groups using a computer-generated list 
(www.randomization.com) with a 1:1 allocation and random block size of 5. At the end, soft 
tissue flaps were repositioned and sutured. All surgical procedures were performed by the 
same calibrated operator. Postoperatively, ibuprenorfine i.m. (0.005mg/kg; Temgesic, 
Schering-Plough, Brussels, Belgium) was administered as analgesic and enrofloxacin i.m. 
(0.5ml/10kg; Baytril 5%, Bayer, Puteaux, France) as antibiotics for 3 days.  
Half of the animals (six) were randomly selected and euthanized after 1 month (1-month 
group) while the remaining ones were euthanized 3 months post-implantation (3-months 
group), through sedation induction by i.m. injection of 1 mL of butyrophenone (Stresnils
®
, 
Ausrichter, Annandale, Australia) followed by an intravascular injection of an embutramide–
mebenzoniumjodide–tetracaıne-HCl solution (1mL/5kg; T61, Intervet, Mechelen, Belgium)
 
into the ear vein until cardiac arrest occurred. It is noteworthy that a second implant per group 
was also inserted in the frontal bone during the surgical procedure but these were not used due 
to the extensive pneumatization of the frontal bone at the time of sacrifice. 
 
Specimen preparation and analysis 
The implant with the surrounding skull bone tissue were harvested, fixed for 4 days in a 
CaCO3-buffered formalin solution and dehydrated in an ascending series of ethanol 
concentrations over a period of 15 days. Embedding was performed by infiltration of a 
Page 10 of 48
Journal of Clinical Periodontology - PROOF
Journal of Clinical Periodontology - PROOF
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
 
benzoylperoxide (0.018%)-methylmetacrylate solution. Samples were sectioned (long axes) 
using a precision diamond saw (Leica SP 1600, Leica Microsystems, Nussloch, Germany). 
The most central section was micro-grinded, polished to a final thickness of 20 to 30 µm 
(Exakt 400 CS, Exakt Technologies Inc., Norderstedt, Germany) and stained with a 
combination of Stevenel's blue and Von Gieson's picrofuchsin red. Therefore, one single 
sample was evaluated per experimental group. All histological and histomorphometrical 
analyses were performed by the same blinded and calibrated examiner. Histological 
examination was performed using a light microscope (×40, ×100 and ×400 magnification; 
Leica Laborlux, Wetzlar, Germany). The images were captured using a high-sensitivity colour 
video camera (JVC TK-1280E, Ibaraki-ken, Japan). The assessment of the 
histomorphometrical data was performed using a commercially available semi-automatic 
image analysis software program (Axiovision 4.0, Zeiss, Gottingen, Germany), with an 
additional customized script (Ogawa et al., 2011). 
Histomorphometrical analyses were performed for 2 implant regions, i.e. the grooved 
(unthreaded) [G] and the threaded lower [T] parts. Measurements were performed at both 
implant sides on each histological section (Fig. 2):  
- Peri-implant bone tissue (B) relative to all tissues (T) (B/T, %) or bone density: the amount 
of bone in the peri-implant region up to 100 µm distance from the implant surface (Fig. 
2A+B); 
- Bone-to-implant-contact (BIC, %): summation of the lengths of contact between bone and 
implant/implant length under consideration (Fig. 2C).  
The primary outcome was defined as the efficiency of different titanium surface 
treatments (H2O, PPA10, PPL1, PPL10, PPL10 BMP) on bone regeneration at 2 specific 
healing times, namely 1 and 4 months. The primary outcome variable was bone density (B/T 
in %) and bone-to-implant contact (BIC in %) within the two regions of interest, i.e groove 
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(G) and thread (T).  The secondary outcome was to define the efficiency of these surface 
treatments on bone regeneration over time (1-month vs 3-month healing times). 
 
Statistical analyses 
The animal was defined as the statistical unit (n=6). Diagnostic tests comprising normal 
probability plots and Shapiro-Wilk tests (software package Statistica; Stat Soft 7.1, Tulsa, 
Oklahoma, USA) were employed to evaluate the homogeneity of the variance and to 
determine whether the residual errors were distributed according to the Gaussian curve. As 
the data did not meet the rigor required by a parametric evaluation, non-parametric tests were 
employed. The Wilcoxon signed-rank test was performed at a significance level of 5% to 
compare pairs of data sets originated from different surface treatments (H20, PPA, PPL1, 
PPL10 and PPL10 BMP) in a particular healing time (1 or 3 months) and a particular area of 
interest (G or T) for each of the selected parameters (B/T and BIC; primary outcome). It 
considers the dependency between pairs of data sets as they were always collected from the 
same animals.  The results obtained for the 1 month and the 3 months groups were also 
compared (secondary outcome) using a non-parametric test for independent samples as pairs 
of data sets under comparison were collected from different animals. In this case, the Mann 
Whitney U-test was used with a significance level of 5%. Multiple testing was used to 
increase the sensitivity of the statistical analysis as the global number of comparisons was too 
large.   
 
RESULTS 
Spectrophotometric Measurement 
The concentration of phosphate was determined by the absorption spectra in molybdenum 
blue solution. No absorption peak was noticed for samples treated with H2O (control) while 
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clear absorption peaks were observed when samples treated with PPA10, PPL1 and PPL10 
were evaluated. The absorbance values for PPA10, PPL1 and PPL10 were 42 x 10
-3
, 6 x 10
-3
 
and 222 x 10
-3
 respectively. 
 
Histological findings 
In one animal (1-month group), signs of inflammation and fibrous tissue invasion at the 
healing sites were observed. These implants were excluded from analysis.  
Bone healing at the implant site occurred intramembraneously and no cartilage tissue 
was observed. After 1 month, ongoing bone formation could be observed with cubical-shaped 
osteoblasts close to the implant surface and areas of new, non-mineralized bone tissue. In the 
group PPL10 BMP, a considerably higher presence of osteoclasts on the implant surfaces 
could be observed (Figure 3). After 3 months, the peri-implant tissue was more organized and 
the prevalence of mineralized bone tissue was observed. Also signs of remodeling, with 
osteoclast activity and the occurrence of basic multicellular units were seen. Figure 4 shows 
ten representative images of the areas of interest (G and T), being one per experimental group 
(H2O, PPA10, PPL1, PPL10 and PPL10 BMP) at each healing time (1 and 3 months). 
 
Histomorphometrical findings 
Results of peri-implant bone formation (B/T) and results of bone-to-implant contact 
(BIC) are and graphically presented in Figures 5 and 6 respectively. These results are also 
descriptively presented in Table 1 including means, medians and standard deviations. For 
each parameter, data are presented per area of interest, namely for the groove (G; Figures 5A 
and 6A respectively) and for the lower screw thread (T; Figures 5B and 6B respectively), and 
this for both 1-month and 3-month healing periods. 
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Significant differences were present for the peri-implant bone formation (B/T) among 
the different surface treatments and the control group (p<0.05). After 1 month, the implants 
treated with PPA10 and with PPL10 showed a significant larger amount of encasing bone at 
the implant groove level compared to the implants in the control H2O group (Fig. 5A; 
p<0.05). The same results were obtained for the implant threaded part (p<0.05), but a 
difference was also found between the implants functionalized with PPA10 and PPL10 when 
compared to the ones incorporated with BMP-2 (PPL10 BMP; p<0.05). The latter showed a 
significant lower amount of bone tissue (Fig. 5B). After 3 months of healing, no statistically 
significant difference was found between control (H2O) and experimental groups (PPA 10, 
PPL1, PPL10 and PPL10 BPM), irrespective of the area of interest (groove or thread; 
p>0.05). At the level of the screw threads (T), on the other hand, a significant difference was 
observed between the PPA10 group and the PPL10 BMP group (p<0.05).   
Significant differences for BIC were found at the implant groove among different 
surface treatments after 1 month (Fig. 6A), with higher BIC values for PPA10 and PPL10 
compared to the control H2O group (p<0.05). This difference was, however, not observed 
after 3 months (p>0.05). Furthermore, more BIC was observed in the groove region of the 
PPA10 implants compared to the PPL10 BMP group after 1 month (p<0.05). Contrary to the 
peri-implant bone formation, some significant differences in BIC between the groups 
persisted over time (3-month groups), in particular between the PPA10 and PPL10 BMP 
groups in the groove area (p<0.05). Additionally, significantly higher BIC values for PPL10 
implants was noted as compared with the BMP-functionalized PPL10 implants (PPL10 BMP 
group) in the groove area at 3-month (p<0.05). With regard to the threaded implant part (Fig. 
6B), significant more BIC was found for the PPA10 and PPL10 groups, compared to H2O 
group (p<0.05), but this was not sustained over time (p>0.05).  
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When results of B/T and BIC were compared over time (1 vs 3 months of healing), no 
statistically significant difference was found (p>0.05) irrespective of the surface treatment 
employed (H2O, PPA 10, PPL1, PPL10 and PPL10 BPM) or the region of interest evaluated 
(groove or thread). 
 
DISCUSSION 
Functionalization of the surface of implants is an actual trend in order to improve the 
integration with biological tissues (Taxt-Lamolle et al. 2010, Wennerberg & Albrektsson 
2010, Cardoso et al. 2014). This study showed that both inorganic and organic phosphate-
containing polymers favor early bone healing surrounding titanium implants, the latter in a 
dose-dependent manner. PPL is supposed to produce a thin coating onto the titanium surface, 
representing a possible alternative approach to foster bone tissue repair and potentially 
engineering.  
A pig animal model was used to simulate the osseointegration in its full complexity 
(Chaudhari et al. 2012, Cardoso et al. 2014). Domestic pigs show considerable bone 
similarities to human beings, including important aspects such as osseous macrostructure, 
microstructure, composition and bone remodeling process and rate, therefore representing a 
suitable option for studies involving implants (Pearce et al. 2007). The calvaria was chosen 
due to its structural similarity to the maxillary region while allowing for a more controllable 
and reproducible surgical procedure when compared to protocols involving intraoral surgery 
(Lutz et al. 2008). Although in vitro testing is an alternative option, the chosen model allowed 
us to demonstrate the behavior of phosphate-containing polymers in a real bone repair 
situation in which not only biological aspects are taken into account but also mechanical 
issues related to the resistance of the coating against the mechanical challenges imposed by 
bone hard tissues while the implant is screwed into the surgical site. In this sense, implants 
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used in this study were customized to provide responses in two different sites. The grooved 
site represented an area of bone regeneration, completely devoid of contact with the walls of 
the bone surgical site (bone defect) at the moment of implantation. On the other hand, the 
threaded site represented an area of initial bone-to-implant juxtaposition (favorable clinical 
situation).  
Implants treated with PPA10 and PPL10 showed higher values of bone formation (B/T) 
and implant osseointegration (BIC) when compared to the non-treated implants (H2O) after 1 
month irrespective of the site to be considered (T or G). These results confirm the 
osteoconductive potential of both inorganic and organic phosphate-containing polymers as 
previously suggested by Cardoso et al. (2014), and this irrespective of the mechanical 
challenge during the insertion of the implant in the surgical site. From a histological and 
biochemical point of view, polyphosphate polymers seem to enhance the attachment and 
proliferation of osteogenic cells (Maekawa et al. 2009) besides inducing their maturation and 
calcification by accelerating alkaline phosphatase and osteocalcin gene expressions 
(Gopalakrishnanchettiyar et al. 2009, Kawazoe et al. 2004). An increase in alkaline 
phosphatase expression shows that the osteoblast activity has progressed to a more 
differentiated state (Anselme et al. 2000). Osteocalcin, in the same context, is a late marker 
associated with extracellular matrix mineralization and is produced by mature osteoblasts 
during bone tissue mineralization. Moreover, superficially adsorbed phosphate groups act as 
specific sites for nucleation of calcium phosphate, which offers preferential binding sites for 
bone cells (Anselme et al. 2000, Sailaja et al. 2009). Finally, Muller et al. (2015) has recently 
shown that polyphosphate stimulates osteoclast-like cells by promoting a significant increase 
in the levels of intracellular and extracellular ATP, thus functioning as a “metabolic fuel” for 
hydroxyapatite formation on the plasma membranes of osteoblasts. 
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Despite all the positive effects of phosphate groups on cell attachment, proliferation and 
differentiation, it should be considered that cell behavior and consequently osseointegration 
can also be greatly influenced by the morphology, roughness and hydrophilicity of the 
implant surface. A hierarchical surface topography including both micron-scale and 
submicron-scale structures seems to be able to promote an enhanced osteogenic effect (Zinger 
et al. 2005). In our study, a machined implant surface devoid of complex topographic 
structures has been employed to avoid that such physical aspects would overshadow the effect 
of the chemical surface modifications, which represent the main object of this study. As 
previously presented, no topographical modification can be expected after treatment of 
titanium surfaces with PPA and PPL in either micro or nanometrical level (Cardoso et al. 
2014), suggesting that all samples employed displayed the same morphology and roughness 
features irrespective of the treatment to which they were submitted. On the other hand, 
wettability has also been reported to influence the interaction between the implant surface and 
the biological environment (Buser et al. 2004). In this sense, a possible increase in 
hydrophilicity promoted by the treatment of the implants with PPA and PPL (Cardoso et al. 
2014) may have played a role on the positive effect of these treatments on bone formation and 
osseointegration. 
The data also showed that the positive results induced by PPA10 and PPL10 after 1 
month of healing did not persist over time. After 3 months, no statistically significant 
difference was found between H2O and PPA10 or PPL10. This suggests that such treatments 
will not necessarily improve osseointegration in a long term, but they are able to accelerate 
bone formation in earlier healing stages. Such faster regeneration is highly desirable as it may 
shorten unloaded healing periods, besides rendering immediate loading protocols more 
successful and predictable. It is indeed in the early stages of bone regeneration that bone-
implant integration is more susceptible to loading challenges (Gapski et al. 2003). A faster 
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regeneration may also be useful in cases of low bone quality due to compromised systemic 
conditions or site-related bone defects.  
 It is noteworthy that no difference was found between PPL1 and the control group H2O 
in terms of bone density and BIC irrespective of the area of interest (G or T), which suggests 
that the positive effect of phosphorylated pullulan may increase in a concentration dependent 
manner. Indeed, our Spectrophotometric measurements showed that treatment with PPA10 
leads to a noticeably higher adsorption of phosphate groups on titanium than its lower 
concentration version (PPA1). This is in line with a previous study in which a higher 
phosphate-titanium ratio tended to accelerate the proliferation of human bone marrow derived 
mesenchymal stem cells (Maekawa et al. 2009). In general, the threaded surface attained 
higher B/T and BIC values compared to the unthreaded implant part, in particular for BIC. An 
increased surface area for the cells to adhere to when initiating bone healing and a tissue 
interlocking more resistant to micro-movements may explain the positive effects of the screw-
shaped implant design. 
Thanks to its unique linkage pattern, pullulan offers interesting physical properties, 
including adhesive ability and the capacity to form thin and transparent biodegradable films 
(Cheng, Demirci & Catchmark, 2011). On the other hand, pullulan films are highly soluble 
(Tong, Xiao & Lim, 2008), leading to a fast release of phosphorylated polymers into the 
regeneration area. Despite its high solubility and consequent fast release, it has been shown 
that phosphorylate polysaccharides remain present on the surface of titanium treated with PPL 
even after active washing and storage in water (Cardoso et al. 2017), which gives us some 
insight on the stability of the coating. The Spectrophotometric measurements in this study 
also confirm the stable adsorption of phosphate-containing polymers on titanium in a 
concentration dependent manner, i.e. higher concentrations of PPL did lead to a higher 
adsorption on the treated surface. However, it remains unknown if the positive effect of PPL 
Page 18 of 48
Journal of Clinical Periodontology - PROOF
Journal of Clinical Periodontology - PROOF
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
 
is due to the phosphorylated polysaccharides which are released in the regeneration area, or 
due to the PPL that remains on the titanium surface as both aspects may be playing a 
simultaneous role. Moreover, it is still questionable if the film-building characteristic of PPL 
had any specific positive effect on bone regeneration and osseointegration. As no statistically 
significant difference was found between PPA10 and PPL10, their positive effect on bone 
tissue activity can only be ascribed to the stimulating effect of phosphate groups.  
The potential use of PPL as carrier for bioactive agents was evaluated via the adsorption 
of 1 µg of BMP2 onto the implant surface functionalized with 10 wt% phosphorylated 
pullulan (PPL10 BMP). The results revealed that BMP2 was not able to improve the healing 
process and even negatively affected the late implant osseointegration (i.e. 3 months healing 
period) at the unthreaded implant part in terms of bone-to-implant contact when compared to 
PPL10. This may at first seem surprising as BMPs are reported to be potent osteoinductive 
morphogens capable of stimulating bone healing (Cheng et al. 2003). However, it has also 
been reported that BMP can exert a negative effect on bone formation (Wikesjö et al. 2008) as 
it may play a role in osteoclastogenesis as receptors for BMPs are also expressed in 
osteoclasts (Kaneko et al. 2000). Although osteoclast activity is inherent in the process of 
bone healing around implants, large doses of BMP-2 may lead to extensive bone re-modelling 
with consequent and undesirable bone loss (Wikesjö et al. 2008, Chaudhari et al. 2012). 
Unfortunately, only limited information is available regarding bone resorption due to a 
particular BMP-2 release via protein delivery carriers (Chaudhari et al. 2012). Additional 
studies are necessary to investigate the most adequate doses of BPM-2 to be adsorbed onto 
PPL-functionalized implants. Alternatively, further modifications in the properties of pullulan 
may be necessary for its use as a BMP-2-release carrier aimed at bone regeneration 
applications. The modifications should aim to a release profile which would induce a bone 
anabolic effect in a consistent, controlled and reproducible manner. 
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CONCLUSION 
Phosphate-containing polymers, whether in their inorganic or organic form, may induce 
extended peri-implant bone formation and osseointegration in early phases of the healing 
process in a dose-dependent manner. Both PPA 10 wt% and PPL 10 wt% promoted higher 
values of B/T and BIC at 1-month healing time. After 3 months of healing, however, PPA and 
PPL seem not to play a role on histomorphometrical outcomes. The association of PPL10 and 
BMP-2 was not successful on promoting improved bone formation and implant 
osseointegration as far as the concentrations and conditions defined in this study are taken 
into account. 
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TABLE 
Table 1. Histomorphometrical results for Bone Fraction (B/T, in %) and Bone-to-implant Contact (BIC, in %) 
Parameter 
Area of 
Interest 
Healing 
Time 
 Mean ± Standard deviation 
Median (Minimum value - Maximum value) 
 H2O PPA10 PPL1 PPL10 PPL10 BMP 
B/T (%) 
Groove 
1 month 
 29.2 ± 13.7 
34.0 (5.5 - 40.6) 
41.5 ± 9.2 
41.0 (31.3 - 53.6) 
36.3 ± 16.4 
35.3 (19.0 - 54.9) 
48.5 ± 7.7 
47.4 (39.7 - 58.6) 
37.7 ± 13.7 
35.3 (23.1 - 59.0) 
3 months 
 45.5 ± 16.5 
48.6 (21.3 - 66.6) 
54.6 ± 15.4 
54.5 (31.8 - 79.3) 
43.6 ± 10.3 
39.8 (35.3 - 62.7) 
51.4 ± 12.7 
57.7 (32.8 - 63.3) 
38.8 ± 7.6 
40.3 (25.5 - 45.7) 
Thread 
1 month 
 48.3 ± 7.5 
48.0 (38.7 - 58.8) 
61.6 ± 10.1 
58.8 (48.1 - 72.5) 
59.0 ± 9.4 
62.4 (43.2 - 67.3) 
60.5 ± 3.1 
59.5 (57.3 - 64.7) 
52.3 ± 9.2 
54.4 (40.6 - 64.5) 
3 months 
 61.5 ± 12.9 
56.5 (51.6 - 85.8) 
71.8 ± 8.0 
71.3 (63.6 - 84.4) 
63.2 ± 13.2 
59.7 (46.2 - 80.9) 
60.4 ± 9.5 
58.7 (50.9 - 74.5) 
57.2 ± 12.4 
56.5 (37.3 - 70.7) 
         
BIC (%) 
Groove 
1 month 
 4.1 ± 4.2 
3.7 (0.0 - 8.9) 
32.6 ± 5.0 
34.3 (26.9 - 38.5) 
24.3 ± 22.0 
13.0 (4.9 - 48.4) 
30.5 ± 20.2 
26.8 (8.4 - 57.8) 
18.0 ± 14.7 
22.0 (0.0 - 36.7) 
3 months 
 17.4 ± 17.0 
17.4 (0.0 - 36.5) 
32.7 ± 23.2 
34.5 (3.9 - 59.5) 
17.4 ± 15.5 
10.3 (7.2 - 47.6) 
28.2 ± 14.2 
20.8 (16.7 - 50.7) 
15.1 ± 6.6 
12.6 (8.9 - 25.4) 
Thread 
1 month 
 28.8 ± 13.6 
26.0 (12.2 - 49.4) 
48.9 ± 17.9 
42.7 (26.8 - 70.2) 
46.5 ± 16.2 
51.0 (19.3 - 60.6) 
47.3 ± 13.0 
53.7 (27.9 - 59.3) 
32.7 ± 10.3 
39.3 (16.8 - 39.8) 
3 months 
 42.8 ± 13.3 
41.8 (23.5 - 64.4) 
47.9 ± 14.2 
42.2 (35.3 - 71.1) 
44.5 ± 14.8 
37.4 (32.1 - 65.4) 
39.4 ± 8.7 
36.9 (28.8 - 52.6) 
36.7 ± 10.4 
41.6 (20.9 - 47.0) 
H2O: distilled water (control); PPA10: polyphosphoric acid 10 wt%; PPL1: phosphorylated pullulan 1wt%; PPL10: phosphorylated pullulan 10 
wt%; PPL10 BMP: phosphorylated pullulan 10 wt% + 1 µg BMP-2. 
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FIGURE LEGENDS 
Fig. 1. Surgical protocol and implants. A) Histological section showing the implant design 
and its osseointegration. Scale bar = 1 mm. B) Details of implant design and its dimensions. 
The grooved [G] and the threaded [T] parts indicate the regions where histomorphometrical 
analyses were performed. C) Anatomy of the pig skull: parietal bones (P); frontal bones (F); 
nasal bones (N). Gray circles show the sites of implantation in the parietal bone. D) Surgical 
site with the implants inserted in the parietal bone. A second implant per group was inserted 
in the frontal bone but these were not used due to the extensive pneumatization of the frontal 
bone at the time of sacrifice.  
 
Fig. 2. Representative histological section of the bone-implant interface. A- Peri-implant bone 
relative to the tissue (B/T): the amount of bone in the peri-implant region up to 100 µm away 
from the implant surface. B - Same image after being digitally processed for 
histomorphometrical analysis. C - Bone-to-implant-contact (BIC): summation of the lengths 
of contact between bone and implant, divided by the implant length under consideration. 
Scale bar: 250 µm. 
 
Fig. 3. Histological analysis of tissue reaction around the surface of an implant treated with 
phosphorylated pullulan at a concentration of 10% wt and incorporated with 1 µg of BMP-2 
per implant (group PPL10 BMP). Sections were stained with a combination of Stevenel’s blue 
and Von Gieson’s picrofuchsin. Note the osteoclast activity around the implant surface 
(arrows).  
 
Fig. 4. Representative histotlogical sections per experimental group at each healing time (1 
month at upper row and 3 months at lower row) showing an overview of the areas of interest 
(groove and thread): [a and f] water (H2O, control group); [b and g] 10% polyphosphoric acid 
(PPA10); [c and h] 1% phosphorylated pullulan (PPL1); [d and i] 10% phosphorylated 
pullulan (PPL10); [e and j] 10% phosphorylated pullulan + 1 µg BMP-2 (PPL10 BMP). Scale 
bar: 1 mm. 
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Fig. 5. Results for the peri-implant bone relative to the tissue (B/T, %), quantified at the 
grooved [G] and the threaded lower [T] part up to 100 µm away from the implant surface. 
Connectives bars indicates means with significant statistical differences (Mann Whitney U-
test with a significance level of 5%). 
 
Fig. 6. Results for bone-to-implant-contact (BIC, %): summation of the lengths of contact 
between bone and implant/implant length under consideration measured at the grooved [G] 
and the threaded lower [T] part. Connectives bars indicate means with significant statistical 
differences (Mann Whitney U-test with a significance level of 5%). 
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Fig. 1. Surgical protocol and implants. A) Histological section showing the implant design and its 
osseointegration. Scale bar = 1 mm. B) Details of implant design and its dimensions. The grooved [G] and 
the threaded [T] parts indicate the regions where histomorphometrical analyses were performed. C) 
Anatomy of the pig skull: parietal bones (P); frontal bones (F); nasal bones (N). Gray circles show the sites 
of implantation in the parietal bone. D) Surgical site with the implants inserted in the parietal bone. A 
second implant per group was inserted in the frontal bone but these were not used due to the extensive 
pneumatization of the frontal bone at the time of sacrifice.  
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Fig. 2. Representative histological section of the bone-implant interface. A- Peri-implant bone relative to the 
tissue (B/T): the amount of bone in the peri-implant region up to 100 µm away from the implant surface. B 
- Same image after being digitally processed for histomorphometrical analysis. C - Bone-to-implant-contact 
(BIC): summation of the lengths of contact between bone and implant, divided by the implant length under 
consideration. Scale bar: 250 µm.  
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Fig. 3. Histological analysis of tissue reaction around the surface of an implant treated with phosphorylated 
pullulan at a concentration of 10% wt and incorporated with 1 µg of BMP-2 per implant (group PPL10 BMP). 
Sections were stained with a combination of Stevenel’s blue and Von Gieson’s picrofuchsin. Note the 
osteoclast activity around the implant surface (arrows).  
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Fig. 4. Representative histological sections per experimental group at each healing time (1 month at upper 
row and 3 months at lower row) showing an overview of the areas of interest (groove and thread): [a and f] 
water (H2O, control group); [b and g] 10% polyphosphoric acid (PPA10); [c and h] 1% phosphorylated 
pullulan (PPL1); [d and i] 10% phosphorylated pullulan (PPL10); [e and j] 10% phosphorylated pullulan + 1 
µg BMP-2 (PPL10 BMP). Scale bar: 1 mm.  
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Fig. 5. Results for the peri-implant bone relative to the tissue (B/T, %), quantified at the grooved [G] and 
the threaded lower [T] part up to 100 µm away from the implant surface. Connectives bars indicates means 
with significant statistical differences (Mann Whitney U-test with a significance level of 5%).  
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Fig. 6. Results for bone-to-implant-contact (BIC, %): summation of the lengths of contact between bone 
and implant/implant length under consideration measured at the grooved [G] and the threaded lower [T] 
part. Connectives bars indicate means with significant statistical differences (Mann Whitney U-test with a 
significance level of 5%).  
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TABLE 
Table 1. Histomorphometrical results for Bone Fraction (B/T, in %) and Bone-to-implant Contact (BIC, in %) 
Parameter 
Area of 
Interest 
Healing 
Time 
 Mean ± Standard deviation 
Median (Minimum value - Maximum value) 
 H2O PPA10 PPL1 PPL10 PPL10 BMP 
B/T (%) 
Groove 
1 month 
 29.2 ± 13.7 
34.0 (5.5 - 40.6) 
41.5 ± 9.2 
41.0 (31.3 - 53.6) 
36.3 ± 16.4 
35.3 (19.0 - 54.9) 
48.5 ± 7.7 
47.4 (39.7 - 58.6) 
37.7 ± 13.7 
35.3 (23.1 - 59.0) 
3 months 
 45.5 ± 16.5 
48.6 (21.3 - 66.6) 
54.6 ± 15.4 
54.5 (31.8 - 79.3) 
43.6 ± 10.3 
39.8 (35.3 - 62.7) 
51.4 ± 12.7 
57.7 (32.8 - 63.3) 
38.8 ± 7.6 
40.3 (25.5 - 45.7) 
Thread 
1 month 
 48.3 ± 7.5 
48.0 (38.7 - 58.8) 
61.6 ± 10.1 
58.8 (48.1 - 72.5) 
59.0 ± 9.4 
62.4 (43.2 - 67.3) 
60.5 ± 3.1 
59.5 (57.3 - 64.7) 
52.3 ± 9.2 
54.4 (40.6 - 64.5) 
3 months 
 61.5 ± 12.9 
56.5 (51.6 - 85.8) 
71.8 ± 8.0 
71.3 (63.6 - 84.4) 
63.2 ± 13.2 
59.7 (46.2 - 80.9) 
60.4 ± 9.5 
58.7 (50.9 - 74.5) 
57.2 ± 12.4 
56.5 (37.3 - 70.7) 
         
BIC (%) 
Groove 
1 month 
 4.1 ± 4.2 
3.7 (0.0 - 8.9) 
32.6 ± 5.0 
34.3 (26.9 - 38.5) 
24.3 ± 22.0 
13.0 (4.9 - 48.4) 
30.5 ± 20.2 
26.8 (8.4 - 57.8) 
18.0 ± 14.7 
22.0 (0.0 - 36.7) 
3 months 
 17.4 ± 17.0 
17.4 (0.0 - 36.5) 
32.7 ± 23.2 
34.5 (3.9 - 59.5) 
17.4 ± 15.5 
10.3 (7.2 - 47.6) 
28.2 ± 14.2 
20.8 (16.7 - 50.7) 
15.1 ± 6.6 
12.6 (8.9 - 25.4) 
Thread 
1 month 
 28.8 ± 13.6 
26.0 (12.2 - 49.4) 
48.9 ± 17.9 
42.7 (26.8 - 70.2) 
46.5 ± 16.2 
51.0 (19.3 - 60.6) 
47.3 ± 13.0 
53.7 (27.9 - 59.3) 
32.7 ± 10.3 
39.3 (16.8 - 39.8) 
3 months 
 42.8 ± 13.3 
41.8 (23.5 - 64.4) 
47.9 ± 14.2 
42.2 (35.3 - 71.1) 
44.5 ± 14.8 
37.4 (32.1 - 65.4) 
39.4 ± 8.7 
36.9 (28.8 - 52.6) 
36.7 ± 10.4 
41.6 (20.9 - 47.0) 
H2O: distilled water (control); PPA10: polyphosphoric acid 10 wt%; PPL1: phosphorylated pullulan 1wt%; PPL10: phosphorylated pullulan 
10 wt%; PPL10 BMP: phosphorylated pullulan 10 wt% + 1 µg BMP-2. 
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SUPPLEMENTARY MATERIAL  
Supporting information for review and online publication only. 
 
Table 1. Results of the Wilcoxon signed-rank test for Bone Fraction (B/T) in the groove area (G) 
at 1-month healing time (p values).  
 H2O PPA10 PPL1 PPL10 PPL10 BMP 
H2O  0.043 0.686 0.043 0.225 
PPA10 0.043  0.686 0.080 0.500 
PPL1 0.686 0.686  0.225 1.000 
PPL10 0.043 0.080 0.225  0.225 
PPL10 BMP 0.225 0.500 1.000 0.225  
H2O: distilled water (control); PPA10: polyphosphoric acid 10 wt%; PPL1: phosphorylated pullulan 1wt%; 
PPL10: phosphorylated pullulan 10 wt%; PPL10 BMP: phosphorylated pullulan 10 wt% + 1 μg BMP-2. 
Statistically significant differences are highlighted in red when p<0.05. 
 
Table 2. Results of the Wilcoxon signed-rank test for Bone Fraction (B/T) in the groove area (G) 
at 3-month healing time (p values).  
 H2O PPA10 PPL1 PPL10 PPL10 BMP 
H2O  0.345 0.753 0.600 0.463 
PPA10 0.345  0.249 0.917 0.116 
PPL1 0.753 0.249  0.345 0.345 
PPL10 0.600 0.917 0.345  0.173 
PPL10 BMP 0.463 0.116 0.345 0.173  
H2O: distilled water (control); PPA10: polyphosphoric acid 10 wt%; PPL1: phosphorylated pullulan 1wt%; 
PPL10: phosphorylated pullulan 10 wt%; PPL10 BMP: phosphorylated pullulan 10 wt% + 1 μg BMP-2. 
Statistically significant differences are highlighted in red when p<0.05. 
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Table 3. Results of the Wilcoxon signed-rank test for Bone Fraction (B/T) in the thread area (T) 
at 1-month healing time (p values). 
 H2O PPA10 PPL1 PPL10 PPL10 BMP 
H2O  0.043 0.138 0.043 0.345 
PPA10 0.043  0.686 0.893 0.043 
PPL1 0.138 0.686  0.893 0.345 
PPL10 0.043 0.893 0.893  0.138 
PPL10 BMP 0.345 0.043 0.345 0.138  
H2O: distilled water (control); PPA10: polyphosphoric acid 10 wt%; PPL1: phosphorylated pullulan 1wt%; 
PPL10: phosphorylated pullulan 10 wt%; PPL10 BMP: phosphorylated pullulan 10 wt% + 1 μg BMP-2. 
Statistically significant differences are highlighted in red when p<0.05. 
 
Table 4. Results of the Wilcoxon signed-rank test for Bone Fraction (B/T) in the thread area (T) 
at 3-month healing time (p values). 
 H2O PPA10 PPL1 PPL10 PPL10 BMP 
H2O  0.116 0.753 0.753 0.600 
PPA10 0.116  0.345 0.116 0.028 
PPL1 0.753 0.345  0.753 0.753 
PPL10 0.753 0.116 0.753  0.600 
PPL10 BMP 0.600 0.028 0.753 0.600  
H2O: distilled water (control); PPA10: polyphosphoric acid 10 wt%; PPL1: phosphorylated pullulan 1wt%; 
PPL10: phosphorylated pullulan 10 wt%; PPL10 BMP: phosphorylated pullulan 10 wt% + 1 μg BMP-2. 
Statistically significant differences are highlighted in red when p<0.05. 
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Table 5. Results of the Wilcoxon signed-rank test for Bone-to-implant Contact (BIC) in the 
groove area (G) at 1-month healing time (p values). 
 H2O PPA10 PPL1 PPL10 PPL10 BMP 
H2O  0.043 0.225 0.043 0.144 
PPA10 0.043  0.225 0.686 0.043 
PPL1 0.225 0.225  0.500 0.686 
PPL10 0.043 0.686 0.500  0.500 
PPL10 BMP 0.144 0.043 0.686 0.500  
H2O: distilled water (control); PPA10: polyphosphoric acid 10 wt%; PPL1: phosphorylated pullulan 1wt%; 
PPL10: phosphorylated pullulan 10 wt%; PPL10 BMP: phosphorylated pullulan 10 wt% + 1 μg BMP-2. 
Statistically significant differences are highlighted in red when p<0.05. 
 
Table 6. Results of the Wilcoxon signed-rank test for Bone-to-implant Contact (BIC) in the 
groove area (G) at 3-month healing time (p values). 
 H2O PPA10 PPL1 PPL10 PPL10 BMP 
H2O  0.345 0.917 0.345 0.600 
PPA10 0.345  0.075 0.753 0.116 
PPL1 0.917 0.075  0.173 0.600 
PPL10 0.345 0.753 0.173  0.028 
PPL10 BMP 0.600 0.116 0.600 0.028  
H2O: distilled water (control); PPA10: polyphosphoric acid 10 wt%; PPL1: phosphorylated pullulan 1wt%; 
PPL10: phosphorylated pullulan 10 wt%; PPL10 BMP: phosphorylated pullulan 10 wt% + 1 μg BMP-2. 
Statistically significant differences are highlighted in red when p<0.05. 
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Table 7. Results of the Wilcoxon signed-rank test for Bone-to-implant Contact (BIC) in the 
thread area (T) at 1-month healing time (p values). 
 H2O PPA10 PPL1 PPL10 PPL10 BMP 
H2O  0.043 0.080 0.043 0.686 
PPA10 0.043  0.686 0.500 0.225 
PPL1 0.080 0.686  0.893 0.225 
PPL10 0.043 0.500 0.893  0.138 
PPL10 BMP 0.686 0.225 0.225 0.138  
H2O: distilled water (control); PPA10: polyphosphoric acid 10 wt%; PPL1: phosphorylated pullulan 1wt%; 
PPL10: phosphorylated pullulan 10 wt%; PPL10 BMP: phosphorylated pullulan 10 wt% + 1 μg BMP-2. 
Statistically significant differences are highlighted in red when p<0.05. 
 
Table 8. Results of the Wilcoxon signed-rank test for Bone-to-implant Contact (BIC) in the 
thread area (T) at 3-month healing time (p values). 
 H2O PPA10 PPL1 PPL10 PPL10 BMP 
H2O  0.917 0.917 0.600 0.249 
PPA10 0.917  0.600 0.249 0.075 
PPL1 0.917 0.600  0.917 0.345 
PPL10 0.600 0.249 0.917  0.600 
PPL10 BMP 0.249 0.075 0.345 0.600  
H2O: distilled water (control); PPA10: polyphosphoric acid 10 wt%; PPL1: phosphorylated pullulan 1wt%; 
PPL10: phosphorylated pullulan 10 wt%; PPL10 BMP: phosphorylated pullulan 10 wt% + 1 μg BMP-2. 
Statistically significant differences are highlighted in red when p<0.05. 
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Table 9. Results of the Mann Whitney U-test comparing results of 1-month vs 3-month healing 
times (p values) for each parameter (B/T and BIC) and each area of interest (G and T). 
 B/T [G] B/T [T] BIC [G] BIC [T] 
H2O (1 month vs 3 months) 0.171 0.083 0.400 0.235 
PPA10 (1 month vs 3 months) 0.121 0.121 1.000 1.000 
PPL1 (1 month vs 3 months) 0.411 0.927 0.784 0.927 
PPL10 (1 month vs 3 months) 0.648 0.784 1.000 0.235 
PPL10 BMP (1 month vs 3 months) 0.523 0.648 0.927 0.235 
H2O: distilled water (control); PPA10: polyphosphoric acid 10 wt%; PPL1: phosphorylated pullulan 1wt%; 
PPL10: phosphorylated pullulan 10 wt%; PPL10 BMP: phosphorylated pullulan 10 wt% + 1 μg BMP-2; 
B/T: bone fraction; BIC: bone-to-implant contact; G: groove; T: thread. Statistically significant differences 
are highlighted in red when p<0.05. 
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RESPONSE TO REVIEWERS MANUSCRIPT ID CPE-09-16-6565    December 28
th
 2016 
 
Titanium implant functionalization with phosphorylated pullulan at specific concentration favors in vivo 
osseointegration   
 
First of all we would like to thank the editors for providing us the opportunity to submit a revised version of our 
manuscript.  We would also like to thank the reviewers for their remarks and suggestions. Please find below a point by 
point answer (in italic) to the comments of the reviewers. The changes in the revised manuscript have been highlighted 
in red. 
 
 
Associate Editor 
 
Comment: Abstract - please clearly indicate the primary outcome parameter as well as the Unit of analysis  
Answer: The primary outcome and unit of analysis are now clearly indicated: “As primary outcome, implant 
osseointegration was evaluated by quantitative histology, namely peri-implant bone formation (B/T in %) and bone-to-
implant contact (BIC in %) for each healing period”. 
 
Comment: Clinical Relevance -All sentence in this section appear to be incomplete and require a proper revision. 
Answer: Sentences were rewritten as such: 
“Scientific rationale for the study: To investigate the influence of different implant surface treatments on the efficiency of 
bone regeneration in a simulated clinical situation.  
Principal findings: Both PPA10 and PPL10 seem to induce faster peri-implant osseointegration and bone regeneration. 
Use of PPL as a carrier for BMP-2 was not efficient on stimulating peri implant bone formation. 
Clinical implications: PPA10 and PPL10 may promote more favorable conditions for early implant loading, particularly in 
unfavorable clinical situations.” 
 
Comment: Introduction - please further elucidate the experimental approach and rationale, as well as its relevance to 
human biology. 
Answer: These aspects have been further elucidated, starting from the relevance to human biology and then the related 
rational for the experimental approach. In the section “Introduction”, we expose the clinical problem, and subsequently 
present a possible solution, the state of the art in this specific field and how the remaining specific doubts could be 
addressed, finally describing the experimental approach and the purpose of the study.  
 
Comment: Materials and Methods:  
• "Animal model, implant and surgical protocol" need to be presented in separate sections 
• please refer to the ARRIVE guidelines when reporting on experimental studies performed in animals 
• please indicate when the study - and in particular the animal experiment - has been carried out 
• information on housing and husbandry is missing 
• conditions and welfare-related assessments and interventions are missing  
Answer: All items requested are now described in a separate sections named “Animal model”, “Implants”, and “Surgical 
Protocol” section. 
We have referred to the ARRIVE guidelines in the sections “Animal model” and “Surgical Protocol”. All items have been 
reported accordingly, including timeline of the study and animal experiment, housing and husbandry information, 
conditions and welfare-related assessment and interventions. 
 
Comment: Materials and Methods: Please explain how the number of animals was arrived at 
Answer: According to Pearce et al (2007), international standards stablish that at least 2 animals should be used for each 
treatment at each healing time when implantation of biomaterials in bone of pigs is considered. Previous research using 
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the same methodology and implantation site (Lutz et al, 2008) showed that the use of 4 animals were sufficient to assure 
statistical significance. To compensate possible drop-outs, while minimizing the number of animals, the sample size per 
group was estimated to be n = 6, i.e. 12 animals in total. This number has been confirmed to be sufficient in some of our 
previous research in which the same methodology was employed (Cardoso et al, 2016). This is now explained in the last 
paragraph of the “Animal model” section. 
 
Comment: Materials and Methods: Give full details of how sites were allocated to experimental groups, including 
randomisation or matching if done.  
Answer: Sites of implantation were randomly allocated to experimental groups using a computer-generated list 
(www.randomization.com) with a 1:1 allocation using random block size of 5. This is now mentioned in the section 
“Surgical protocol”. 
 
Comment: Materials and Methods: Primary and secondary outcomes must be clearly defined. 
Answer: Primary and secondary outcomes are now clearly defined in the last paragraph of the “Specimen preparation 
and analysis” and the “Statistical analyses” sections of Materials and Methods, as mentioned below: 
“The primary outcome was defined as the efficiency of different titanium surface treatments (H2O, PPA10, PPL1, PPL10, 
PPL10 BMP) on bone regeneration at 2 specific healing times, namely 1 and 4 months. The primary outcome variable was 
bone density (B/T in %) and bone-to-implant contact (BIC in %) within the two regions of interest, i.e groove (G) and 
thread (T).  The secondary outcome was to define the efficiency of these surface treatments on bone regeneration over 
time (1-month vs 3-month healing times).” 
“The Wilcoxon signed-rank test was performed at a significance level of 5% … for each of the selected parameters (B/T 
and BIC; primary outcome)”. 
“The results obtained for the 1 month and the 3 months groups were also compared (secondary outcome) using … the 
Mann Whitney U-test”. 
 
Comment: Materials and Methods: calibration/ blinding of the examiner/s is missing 
Answer: All surgical procedures were performed by the same calibrated operator. This is now mentioned in the section 
“Surgical protocol”. All histological and histomorphometrical analyses were performed by the same blinded and 
calibrated examiner. This is now mentioned in the section “Specimen preparation and analysis”. 
 
Comment: Materials and Methods: Histological analysis - how many samples were stained and evaluated per 
experimental site? 
Answer: One single sample, the most central one, was stained and evaluated per experimental site. This is mentioned in 
the section “Specimen preparation and analysis”. 
 
Comment: Materials and Methods: Statistics: how did the authors account for multiple-testing? 
Answer: Multiple testing was used to increase the sensitivity of the statistical analysis as the global number of 
comparisons is too large. In other words, we opted for an exploratory analysis so that statistically significant differences 
would become more evident. 
On the other hand, the specific non-parametric tests employed (Wilcoxon signed-rank test and Mann Whitney U-test) 
comply with 2 different criteria of dependency between data sets. 
When comparing the performance of different surface treatments at the same healing time (1 or 3 months), the 
statistical analysis should take into account the dependency between data sets as implants from the 5 different groups 
were installed in the same animal (experimental unit). In this case, the Wilcoxon signed-rank test was used. 
On the other side, when comparing the performance of the different surface treatments over time (1 vs 3-month 
healing), independency between data sets should be considered as implants  were installed in differences animals. In this 
case, Mann Whitney U-test was used. 
This reasoning is now mentioned in the section “Statistical analysis”. 
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We also noticed that the results of the Mann Whitney U-test were not described in the Results. This is now mentioned 
accordingly in the last paragraph of the chapter “Results”. 
 
Comment: Discussion: Statistics: please discuss why the implants have not been placed in the mandible - what is the 
clinical relevance of data collected in the parietal bone? 
Answer: As clarified in the 2
nd
 paragraph of the Discussion, “domestic pigs show considerable bone similarities to human 
beings, including important aspects such as osseous macrostructure, microstructure, composition and bone remodeling 
process and rate, therefore representing a suitable option for studies involving implants (Pearce et al. 2007). The calvaria 
was chosen due to its structural similarity to the maxillary region while allowing for a more controllable and reproducible 
surgical procedure when compared to protocols involving intraoral surgery (Lutz et al. 2008)”. 
By opting for the parietal bone, we avoided external factors that could interfere with the osseointegration and 
overshadow the effect of the proposed treatments, such as difficulties during the surgical procedure, contamination, 
movement of remaining teeth and damages in the surgical area due to masticatory function. 
 
Comment: Figures: lower magnification views should also be included for all groups. 
Answer: Figure 4 was included with lower magnification views of representative images of the areas of interest (groove 
and thread), being one per experimental group at each healing time. This figure has been mentioned in the text in the 
section Results/Histological findings. 
 
 
Editor in Chief Comments. 
 
Comment: A critical question needs to be addressed: lots of studies are attempting to modify titanium in order to 
improve its biological performance. Many of these studies are published in more specialized Journals. Why should JCP 
publish this specific report? Does it have a significantly different potential for clinical application? How does this relate 
to many other approaches being investigated? 
Answer: Our decision to submit this manuscript to JCP was indeed based on the scope of this periodic. The first section of 
the Author’s guidelines mentions that “JCP publishes original contributions on high scientific merit in the fields of 
periodontology and implant dentistry”. Our research explores important aspects in both fields. Specifically about of the 
scope of the Journal, it is clear that it “encompasses a lot of specific fields, among then, tissue osseointegration of dental 
implants, bone healing and regeneration, the clinical aspects of tooth replacement with dental implants and finally, 
advances in implant techniques and procedures”, which closely reflects the scope of our research.  
Regarding to the potential for clinical application, our experiment evaluates different implant surface treatments with 
direct potential for clinical application. This stage of maturity in our research line is a result of many successful previous 
exploratory studies involving: 
• surface characterization of titanium treated with different concentrations of organic and inorganic phosphate-
containing polymers; 
• in vitro mesenchymal cell behavior on titanium treated with these polymers; 
• and in vivo proof of concept involving small animal models in less clinically significant set-ups. 
The aim of the current study is to contribute with a clinically relevant information and provide different options to 
improve the speed and the quality of the osseointegration. 
 
 
Comment: are there potential conflict of interest that need to be disclosed? 
Answer: As stated in the Wiley’s Conflict of Interest Form, there is no conflict of interest to be disclosed. 
 
 
Referee 1 Comments. 
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Comment: The implant has 2 different diameters, thus the smaller one may prevent risk for the coat to be detached at 
least in that area during installation but do the authors have any information on the stability of the coat? Durability? 
Answer: Thanks to its unique linkage pattern, pullulan offers interesting physical properties, including adhesive ability 
and the capacity to form thin and transparent biodegradable films (Cheng, Demirci & Catchmark, 2011). On the other 
hand, pullulan films are highly soluble (Tong, Xiao & Lim, 2008), leading to a fast release of phosphorylated polymers into 
the regeneration area.  
To evaluate if any phosphorylated pullulan remains on the titanium surface after the solubility of the coating, we used a 
Shimadzu IRAffinity-1 FTIR Spectrophotometer (Shimadzu, Japan). As shown in the Figure below, the FTIR spectra of PPL-
treated titanium revealed three absorption bands around 1000-1250 cm−1, which were not present in the FTIR spectra of 
pure titanium. These three absorption bands are attributed to PPL. These peaks remained present even after active 
washing and storage in water for 1 week. These results confirm the presence of a stable layer of PPL on the treated Ti 
surfaces. 
 
This chemical characterization was used in another study which, in the meantime, has been accepted for publication 
(Cardoso et al., 2017). Therefore, this can now be used as a reference in the present study, as included in the 3
rd
 
paragraph of the section Discussion. It remains, however, unknown if the positive effect of PPL is due to the 
phosphorylated polysaccharides which are releas d in the regeneration area, or due to the molecules that remain on the 
titanium surface. 
Finally, implants treated with PPL10 showed higher values of bone formation (B/T) and implant osseointegration (BIC) 
when compared to the non-treated implants (H2O) after 1 month irrespective of the site to be considered (thread or 
groove). This shows the positive effect of PPL irrespective of the mechanical challenge during the insertion of the implant 
in the bone. This is now also discussed in the 7
th
 paragraph of the Discussion chapter. 
 
Comment: Did the coat influence the surface topography on a micro or nano level? 
Answer: The topography of the implants is indeed an important aspect to be taken into account. According to the 4
th
 
paragraph of the section Discussion, “A hierarchical surface topography including both micron-scale and submicron-scale 
structures seems to be able to promote an enhanced osteogenic effect (Zinger et al. 2005). In our study, a machined 
implant surface devoid of complex topographic structures has been employed to avoid that such physical aspects would 
overshadow the effect of the chemical surface modifications, which represent the main object of this study. As previously 
presented, no topographical modification can be expected after treatment of titanium surfaces with PPA and PPL in 
either micro or nanometrical level (Cardoso et al. 2014), suggesting that all samples employed displayed the same 
morphology and roughness features irrespective of the treatment to which they were submitted”.  
Small modifications in the text have been done to emphasize that PPL and PPA are not able to modify the surface 
topography in either micro or nanometrical level. 
 
Comment: The title do not correspond very well with the achieved results, more correct would be “…may favor early 
bone formation…” 
Answer: The title has been adapted according to the reviewer’s suggestion. 
 
 
Referee 2 Comments. 
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Comment: Both polyphosphoric acid at 10% and phosphorylated pullulan at 10% achieved better results in comparison 
to the control with water. Why is in the entire manuscript only the effect of phosphorylated pullulan discussed? Why it 
is only concluded that phosphorylated pullulan rendered a positive effect on the osseointegration? Based on the results 
it should be concluded that both polyphosphoric acid at 10% and phosphorylated pullulan at 10% stimulate the 
osseointegration. 
Answer: We have emphasized the role of PPL on osseointegration as the role of PPA has already been reasonably 
explored in some of our previous studies (Maekawa et al., 2007, 2008 and 2009). Differently form PPA, PPL presents 
specific characteristics which allows it to be used as a carrier for drugs or growth factors, as explored in the present 
research. 
Anyway, the function of PPA on osseointegration is presented in the 2
nd
 and 3
rd
 paragraphs of the section “Introduction”, 
and in many passages throughout the discussion. 
The conclusion sections have been rephrased as indicated by the reviewer, including PPA 10 wt%: 
Conclusion at the Abstract: “Functionalizing titanium implants with inorganic or organic phosphate-containing polymers 
at 10 wt% concentration may stimulate peri-implant bone formation and implant osseointegration at early healing 
times”. 
Conclusion in the main manuscript: “Phosphate-containing polymers, whether in their inorganic or organic form, may 
induce extended peri-implant bone formation and osseointegration in early phases of the healing process in a dose-
dependent manner. Both PPA 10 wt% and PPL 10 wt% promoted higher values of B/T and BIC at 1-month healing time. 
After 3 months of healing, however, PPA and PPL seem not to play a role on histomorphometrical outcomes”. 
 
Comment: The differences between these two substances (polyphosphoric acid and phosphorylated pullulan) need 
further explanation. 
Answer: As mentioned in the manuscript, PPA is an inorganic polymer while PPL is an organic polymer. Differently from 
PPA, which is artificially developed, pullulan is all natural while modified to include phosphorus into the polymer chain. 
However, in the context of the present study, the main difference between these two substances is that, as a 
polysaccharide, PPL can form a film on the treated surface which can be further investigated for the immobilization of 
growth factors or gene therapy. Actually, this is also the reason why this manuscript focus more on the effects of PPL 
than PPA. The potential effects of phosphate groups on bone regeneration are well stablished. The purpose of our 
research line is to advance one step further and investigate the use of PPL as a carrier. We started showing the potential 
of phosphate groups on cell attachment, proliferation and differentiation (Maekawa et al, 2007 and 2008), and went 
further with a “proof of concept” study, showing that phosphate based polymers (inorganic and organic) are both able to 
stimulate bone regeneration in an animal model (Cardoso et al., 2014). At the moment, our work investigates the use of 
PPL in clinically relevant situations to then further develop on its potential use as a biological carrier for growth factor or 
drug delivery, as investigated in other areas of medicine (Morimoto et al. 2005, Kato et al. 2007, Prajapati et al. 2013). 
The present study already initiates this next phase of our research line by investigating the possible use PPL as a carrier 
for BMP-2. 
All these aspects are already present in the Introduction section. We have made some small modifications in the text to 
emphasize the difference between PPA and PPL (4
th
 paragraph of the Introduction). 
 
Comment: As far as the interpretation is concerned, it is questionable whether the film-building pullulan had any effect. 
Indeed, polyphosphoric acid alone rendered the highest mean values. This fact should be discussed. 
Answer: From the statistical point of view, no significant difference was observed between polyphosphoric acid and 
phosphorylated pullulan in terms of bone regeneration and osseointegration, irrespective of concentration, area of 
interest or healing time. Therefore, we completely agree with the reviewer: the positive effect of PPL10 cannot be 
ascribed to its film-building characteristic. We have now made it clear in the 7
th
 paragraph of the Discussion section. 
Once both PPA and PPL present similar positive effect on bone regeneration, the film-building feature of PLL remains a 
potential advantage over PPA as it may work as a potential carrier for drug delivery or gene therapy. We already started 
exploring this aspect in the present study by combining PPL with BMP-2. Further studies are necessary in this sense, as 
exposed in the last sentences of the section Conclusion. 
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Comment: 2. P-values should be reported in the Results section. It is recommended to include the tables containing the 
results of the descriptive analysis (means, medians, SD, ranges) and the exact P-values. 
Answer: P values are now reported in the Results section (p>0.05 or p<0.05). Table 1 was included and contains the 
results of the descriptive analysis (means, SD, medians and ranges). Because we opted for multiple testing in the 
statistical analyses to compensate the large number of comparisons, it becomes difficult to present all exact P-values in 
the manuscript itself. Therefore, to fulfill the request of the reviewer, we prepared 9 Tables will all p values as 
Supplementary Material, “Supporting information for review and online publication only”, as suggested in the Guidance 
for Authors of Journal of Clinical Periodontology. 
 
Comment: 3. For better understanding, it is recommended to use entire sentences in the chapter Clinical relevance. 
Answer: The chapter “Clinical Relevance” has been rewritten according to the suggestion of the reviewer, as presented 
below: 
“Scientific rationale for the study: To investigate the influence of different implant surface treatments on the efficiency of 
bone regeneration in a simulated clinical situation.  
Principal findings: Both PPA10 and PPL10 seem to induce faster peri-implant osseointegration and bone regeneration. 
Use of PPL as a carrier for BMP-2 was not efficient on stimulating peri implant bone formation. 
Clinical implications: PPA10 and PPL10 may promote more favorable conditions for early implant loading, particularly in 
unfavorable clinical situations.” 
 
 
Comment: 4. An image of the experimental region would be valuable, since the applied model with implant placement 
in porcine skull is not widely used. 
Answer: We included two images in Fig 1 (C and D). Fig 1C shows the anatomy of a pig skull and Fig 1D shows the 
surgical site with the implants inserted in the parietal bone. Text and Figure legends were adapted accordingly. 
 
Comment: 5. The number of implants, their bilateral distribution and the distance between the implants need to be 
clearly described. 
Answer: This information is now described in the “Surgical protocol” section: “Five implantation sites were drilled in a 
transversal sequence in the parietal bones 0.6 mm far from the coronal suture (Fig. 1C and 1D). Two of these sites were 
drilled on the right parietal bone while the other three on the left parietal bone, always keeping a distance of about 12 
mm between adjacent drilling sites”. The allocation of the experimental groups per site is now also described in the same 
section: “Sites of implantation were randomly allocated to experimental groups using a computer-generated list 
(www.randomization.com) with a 1:1 allocation and random block size of 5”. 
 
Comment: 6. Conclusions: “Phosphate-containing polymers, whether in their inorganic or organic form...“. Can a 
polymer be inorganic? “...when clinically relevant aspects are taken into account”. This part of the sentence is not clear. 
Answer: Indeed, a polymer can be both organic and inorganic. There are many polymers which do not have Carbon in 
their backbone. Their backbones are made of atoms such as silica, boron, sulphur, etc. Similarly, phosphorus atoms can 
also form the backbone of a polymer, as in case of polyphosphoric acid (PPA). When two orthophosphoric acid molecules 
are condensed into one molecule, pyrophosphoric acid (H4P2O7) is obtained. Further orthophosphoric acid molecules can 
be condensed into this molecules one by one to form polyphosphoric acid. Polyphosphoric acid molecules can have 
dozens of such phosphoric units bonded in a row. 
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Throughout the text, more specifically in the Introduction and Discussion sections, we mention that one of the purposes 
of this study is to evaluate the effect of the studied treatments in a “more clinically relevant situation” as these 
treatments have already proven to be efficient in some of our previous studies involving cell-culture (Maekawa et al, 
2007 and 2008) and animals in a “proof of concept” methodology (Maekawa et al., 2009, Cardoso et al., 2014). In the 
present study, the clinical relevance lays on the fact that the implants are actively screwed into the bone and that the 
used animal model closely simulates the bone metabolism of human beings (Pearce et al., 2007).  
To avoid misinterpretations, this sentence was deleted from the Conclusion section. 
 
Comment: 7. „Additional studies should define the ideal concentration of BPM-2 to be incorporated in phosphorylated 
pullulan solutions aiming at enhanced bone healing. Alternatively, further modifications in the physical properties of PPL 
are necessary before it can be promoted as a carrier for BMP-2 in bone regeneration applications. It is recommended to 
move these sentences to the Discussion section and to limit the Conclusions to the outcomes of the study. 
Answer: As suggested by the reviewer, these sentences were deleted from the conclusions and are part of the 
“Discussion” chapter (last sentences of the last paragraph). 
To avoid misunderstanding, we have clarified in the Conclusion chapter that “The association of PPL10 and BMP-2 was 
not successful on promoting improved bone formation and implant osseointegration as far as the concentrations and 
conditions defined in this study are taken into account.” 
 
 
Comment: 8. Some images are too small and cannot be assessed 
Answer: We have reassessed the images so that they are presented in sufficient size/resolution. 
 
 
Referee 3 Comments. 
 
Comment: The input of animals and effort was immense; the outcome not that spectacular. Especially after 3 month no 
beneficial effect is seen by any surface modification.  
Answer: Statistically significant differences were found at 1-month healing time, showing that both PPL10 and PPA10 
may play a positive role in improving bone regeneration. The fact that no beneficial effect was found at 3-month healing 
time does not concern us as the osseointegration process is mostly critical in early healing stages or in cases of local or 
systemic challenges. To emphasize this aspect, we have included the following text in the 5
th
 paragraph of the Discussion: 
“This suggests that such treatments will not necessarily improve osseointegration in a long term, but they are able to 
accelerate bone formation in earlier healing stages. Such faster regeneration is highly desirable as it may shorten 
unloaded healing periods, besides rendering immediate loading protocols more successful and predictable. It is indeed in 
the early stages of bone regeneration that bone-implant integration is more susceptible to loading challenges (Gapski et 
al. 2003). A faster regeneration may also be useful in cases of low bone quality due to compromised systemic conditions 
or site-related bone defects”. 
 
Comment: Surface treatment should be described in great detail. 
Answer: Surface treatment is now described in full details in the section “Implants” of “Materials and Methods”. To 
comply with a reasonable lengthening of the text, the synthesis of phosphorylated pullulan has not been described in 
detailed. Alternatively, we opted to refer to another study in which this process is fully described. This can be found in the 
text as such: “The synthesis of PPL was processed as previously described in detail by Cardoso et al. (2014)”. 
 
Comment: The source and characterization of PPA is missing. 
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Answer: This is now mentioned in the section “Implants” of “Materials and Methods”: “Treatment of the implants with 
PPA10 was done by immersion in 10 wt% PPA solution for 24 h at 37°C. This solution was obtained by dissolving 10 g of 
100% PPA (Merck Schuchardt, Hohenbrunn, Germany) in 100 ml of distilled water”. 
 
Comment: How much PPA or PPL was bound? 
Answer: The chemical analysis of Ti surfaces treated with different concentrations of PPA has been evaluated and 
presented in one of our previous publications (Maekawa et al., 2007). By using XPS, we found that the average P/Ti ratio 
of the treated titanium surfaces increased significantly following a PPA concentration dependency. Significantly higher 
P/Ti ratios were observed on surfaces treated with polyphosphoric acid at 10 wt% as compared to lower concentrations 
(0,1 and 1 wt%). In this study, it was observed that PPA10 induced higher mesenchymal cell proliferation than its PPA in 
lower concentrations. 
The chemical analysis of Ti surfaces treated with PPL10 has been evaluated using a Shimadzu IRAffinity-1 FTIR 
Spectrophotometer and presented in one of our previous publications (Cardoso et al., 2017, in press). The FTIR spectra of 
PPL-treated titanium revealed absorption bands attributed to PPL. These peaks remained present even after active 
washing and storage in water for 1 week. These results confirm the presence of a stable layer of PPL on the treated Ti 
surfaces. This is now mentioned in the 7
th
 paragraph of the section “Discussion”.  
Quantification of bounded PPA and PPL was measured and included in the text as described below: 
• Materials and Methods: last paragraph of the “Implants” section; 
• Results: “Spectrophotometric Measurement” section; 
• Discussion: 7
th
 paragraph  
“The Spectrophotometric measurements in this study also confirm the stable adsorption of phosphate-containing 
polymers on titanium in a concentration dependent manner, i.e. higher concentrations of PPL did lead to a higher 
adsorption on the treated surface”. 
• Discussion: 6
th
 paragraph 
“Indeed, our Spectrophotometric measurements showed that treatment with PPA10 leads to a noticeably higher 
adsorption of phosphate groups on titanium than its lower concentration version (PPA1).” 
 
 
Comment: Was the bound BMP still bioactive? 
Answer: To assure that BMP-2 was still bioactive, it was reconstituted as per the instructions of the manufacturer. The 
implants were treated with the reconstituted protein at room temperature in sterile environment and then implanted 
immediately once dried. Care was taken not to contaminate the protein or to change the environmental temperature to 
denature the protein. This is now mentioned in the section “Implants” of “Materials and Methods”. 
In one of our previous studies in which the same methodology was used (Chaudhari et al., 2013), the BMP-2 bound to 
titanium surface was kept in cell culture medium. The protein released to the cell culture medium was then measured 
using ELISA. Binding of these released protein to the ELISA plate shows that the protein was still bioactive. 
 
Comment: Why use pullulan when PPA works also efficiently? 
Answer: As mentioned in the manuscript, PPA is an inorganic polymer while PPL is an organic polymer. Differently from 
PPA, which is artificially developed, pullulan is all natural while modified to include phosphorus into the polymer chain. 
However, in the context of the present study, the main difference between these two substances is that, as a 
polysaccharide, PPL can form a film on the treated surface which can be further investigated for the immobilization of 
growth factors or gene therapy. Actually, this is also the reason why this manuscript focus more on the effects of PPL 
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than PPA. The potential effect of phosphate groups on bone regeneration is well stablished. The purpose of our research 
line now is to advance in this subject and investigate the use of PPL as a carrier. We started showing the potential of PPA 
on cell attachment, proliferation and differentiation (Maekawa et al, 2007 and 2008), and went further with a “proof of 
concept” study, showing that phosphate based polymers (inorganic and organic) are both able to stimulate bone 
regeneration in an animal model (Cardoso et al., 2014). At the moment, our work investigates the use of PPL in clinically 
relevant situations to then further develop on its potential use as a biological carrier for growth factor or drug delivery, 
as investigated in other areas of medicine (Morimoto et al. 2005, Kato et al. 2007, Prajapati et al. 2013). The present 
study already initiates this next phase of our research line by investigating the possible use PPL as a carrier for BMP-2.  
All these aspects are already present in the Introduction section. We have made some modifications in the text to explain 
the difference between PPA and PPL and to emphasize the advantages of PPL (4th paragraph of the Introduction). 
Once both PPA and PPL present similar positive effect on bone regeneration, the film-building feature of PLL remains a 
potential advantage over PPA as it may work as a potential carrier for drug delivery or gene therapy. We already started 
exploring this aspect in the present study by combining PPL with BMP-2. Because the results were not so promising in this 
sense, further studies are necessary to explore this field of expertise, as exposed in the last sentences of the section 
Conclusion. 
 
Comment: On PPA work of WEG Müller has to be cited. He has also shown positive effect of PPA on bone regeneration. 
Answer: The work of WEG Muller is indeed outstanding and has been cited accordingly (3
rd
 paragraph of the Discussion 
chapter): 
“Finally, Muller et al. (2015) has recently shown that polyphosphate stimulates osteoclast-like cells by promoting a 
significant increase in the levels of intracellular and extracellular ATP, thus functioning as a “metabolic fuel” for 
hydroxyapatite formation on the plasma membranes of osteoblasts”. 
 
Comment: The BIC-figure is too small to be evaluated properly. 
Answer: We have reassessed the images so that they are presented in sufficient size/resolution. 
 
 
References for the revision 
Lutz, R., Park, J., Felszeghy, E., Wiltfang, J., Nkenke, E., Schlegel, K.A. (2008) Bone regeneration after topical BMP-2-bone 
delivery in circumferential peri-implant bone defects. Clinical Oral Implants Research 19,590-599. 
Pearce, A.I., Richards, R.G., Milz, S., Schneider, E., Pearce, S.G. (2007) Animal models for implant biomaterial research in 
bone: a review. European Cells Materials 13, 1-10. 
Cardoso, M. V., Chaudhari, A., Yoshida, Y., Van Meerbeek, B., Naert, I., Duyck, J. (2014) Bone tissue response to implant 
surfaces functionalized with phosphate-containing polymers. Clinical Oral Implants Research 25, 91-100. 
Cardoso, M. V., Chaudhari, A., Yoshihara, K., Yoshida, Y., Van Meerbeek, B., Vandamme, K., Duyck, J. (2017) 
Phosphorylated pullulan coating enhances titanium implant osseointegration in a pig model. The International Journal of 
Oral & Maxillofacial Implants, in press. 
Chaudhari, A., Duyck, J., Braem, A., Vleugels, J., Petite, H., Logeart-Avramoglou, D., Naert, I., Martens, J. A., Vandamme, 
K. (2013) Modified Titanium Surface-Mediated Effects on Human Bone Marrow Stromal Cell Response. Materials 6, 
5533-48. 
Cheng, K. C., Demirci, A., Catchmark, J. M. (2011) Pullulan: Biosynthesis, production, and applications. Applied 
Microbiology and Biotechnology 95, 29–44. 
Kato, N., Hasegawa, U., Morimoto, N., Saita, Y., Nakashima, K., Ezura, Y. (2007) Nanogel-based delivery system enhances 
PGE2 effects on bone formation. Journal of Cellular Biochemistry 101, 1063–70. 
K., Shimono, K., Oshima, M., Yoshida, Y., Van Meerbeek, B., Suzuki, K. (2009) Polyphosphoric acid treatment promotes 
bone regeneration around titanium implants. Journal of Oral Rehabilitation 36,362–7. 
Page 47 of 48
Journal of Clinical Periodontology - PROOF
Journal of Clinical Periodontology - PROOF
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
10 
 
Maekawa, K., Yoshida, Y., Mine, A., Fujisawa, T., Van Meerbeek, B., Suzuki, K. Kuboki, T. (2007) Chemical interaction of 
polyphosphoric with titanium and its effects on human bone marrow derived mesenchymal stem cell behavior. Journal 
of Biomedical Materials Research Part A 82,195–200. 
Maekawa, K., Yoshida, Y., Mine, A., Van Meerbeek, B., Suzuki, K. Kuboki, T. (2008) Effect of polyphosphoric pre-
treatment of titanium on attachment, proliferation, and differentiation of osteoblast-like cells (MC3T3-E1). Clinical Oral 
Impants Research 19, 320–5. 
Morimoto, N., Endo, T., Ohtomi, M., Iwasaki, Y., Akiyoshi, K. (2005) Hybrid nanogels with physical and chemical cross-
linking structures as nanocarriers. Macromolecular Bioscience 5, 710–6. 
Tong, Q.Y., Xiao, Q., Lim, L.T. (2008) Preparation and properties of pullulan-alginate-carboxymethylcellulose blend films. 
Food Res Int 41,1007-1014. 
Page 48 of 48
Journal of Clinical Periodontology - PROOF
Journal of Clinical Periodontology - PROOF
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
